PMID- 16903003 OWN - NLM STAT- MEDLINE DCOM- 20070515 LR - 20131121 IS - 0277-6715 (Print) IS - 0277-6715 (Linking) VI - 26 IP - 7 DP - 2007 Mar 30 TI - Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses. PG - 1518-31 AB - In each clinical trial the statistical evaluation of adverse events (AEs) is a major part of standard safety analyses. However, the analyses of AEs usually lack from adequately accounting for the occurrence of multiple, different AEs. Furthermore, predictive variables other than treatment such as age, sex and concomitant medication are often ignored. These issues can be addressed by the Cox regression as introduced by Andersen and Gill and Wei et al. A further issue arises from the fact that an ordered programme of studies is conducted during clinical testing of pharmaceutical drugs. In this paper, we therefore discuss a stratified multivariate Cox regression model that can be used in integrated summaries of safety. We derive partial maximum likelihood estimators of the model parameters which can be shown to be consistent and asymptotically normally distributed. Mainly based on a sandwich estimator of their covariance matrix several test statistics are proposed that can be used to test various null hypotheses on the underlying parameters. Their asymptotic null distributions are given. The benefit of this survival time approach for analysing AEs is illustrated by evaluating symptoms of common cold from the database of a clinical development project. CI - Copyright (c) 2006 John Wiley & Sons, Ltd. FAU - Guttner, Achim AU - Guttner A AD - Novartis Pharma AG, Biostatistics and Statistical Reporting, CH-4002 Basel, Switzerland. achim.guettner@novartis.com FAU - Kubler, Jurgen AU - Kubler J FAU - Pigeot, Iris AU - Pigeot I LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Stat Med JT - Statistics in medicine JID - 8215016 RN - 0 (Cholinesterase Inhibitors) SB - IM MH - Alzheimer Disease/drug therapy MH - Cholinesterase Inhibitors/adverse effects/therapeutic use MH - Clinical Trials as Topic/*methods MH - Common Cold/chemically induced MH - *Drug-Related Side Effects and Adverse Reactions MH - Humans MH - Meta-Analysis as Topic MH - *Multivariate Analysis MH - *Proportional Hazards Models MH - Randomized Controlled Trials as Topic/methods EDAT- 2006/08/12 09:00 MHDA- 2007/05/16 09:00 CRDT- 2006/08/12 09:00 PHST- 2006/08/12 09:00 [pubmed] PHST- 2007/05/16 09:00 [medline] PHST- 2006/08/12 09:00 [entrez] AID - 10.1002/sim.2637 [doi] PST - ppublish SO - Stat Med. 2007 Mar 30;26(7):1518-31. doi: 10.1002/sim.2637.